BioBusiness is:
More Value for Money:
- Over twice as much content as 2011 over three packed days
- Almost double the number of speakers - 65+ thought-leaders
- Multiple streams – customise and prioritise your conference agenda
More Senior & Strategic:
- Forward looking content tackling issues that matter
- Senior advisory panel directing the agenda
- Pharma VPs – EVPs, CEOs from Biotech and Partner – CEOs from VCs speaking
More International, Less Parochial:
- Over 30% of our speakers from beyond Europe to the US and Asia
- Brand new speakers and industry titans
- Issues affecting the global biopharma community
Issues that matter to you:
- Early stage funding
- R&D efficiency and externalisation
- Payer’s perspectives
- Corporate venture capital trends
- Deal structures and trends
- Alliance management
- Outlicensing, divestment and spinouts
Find out why BioBusiness is unique